After a very profitable decade on Microsoft's board, Reid Hoffman is stepping down to focus on his AI drug discovery startup Manus.... https://techcrunch.com/2026/06/05/reid-hoffman-is-leaving-microsofts-board-to-go-founder-mode-with-startup-manus/